The Epithelial Sodium Channel α subunit (α ENaC) alternatively spliced form "b" in Dahl rats: What's next? by Shehata, Marlene F
Shehata International Archives of Medicine 2010, 3:14
http://www.intarchmed.com/content/3/1/14
Open Access HYPOTHESIS
© 2010 Shehata; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons At-
tribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Hypothesis The Epithelial Sodium Channel α subunit (α ENaC) 
alternatively spliced form "b" in Dahl rats: What's 
next?
M a r l e n eFS h e h a t a
Abstract
Background: The amiloride-sensitive Epithelial Sodium Channel (ENaC) is critical in maintaining Na+ balance, 
extracellular fluid volume and long term blood pressure control. ENaC is composed of three main subunits α, β, & γ. 
While α ENaC is critical for channel functionality, β & γ ENaC maximize channel function. To date, there are four 
alternatively spliced forms of the α subunit of ENaC (α ENaC-a, -b, -c, & -d) that have been published in rats, in addition 
to the major α ENaC transcript. While α ENaC-a, -c & -d transcripts are low abundance transcripts compared to full-
length α ENaC, α ENaC-b is a higher abundance and salt-sensitive transcript compared to full-length α ENaC.
Presentation of the hypothesis: α ENaC-b protein, which is preferentially produced in Dahl R rats, to a greater extent 
on high salt diet, exerts a dominant negative effect on full-length α ENaC subunit by physically binding to and trapping 
full-length α ENaC subunit in the endoplasmic reticulum, and finally accelerating full-length α ENaC proteolytic 
degradation in a dose-dependent manner.
Testing the hypothesis: 1) To examine the mRNA and protein abundance of α ENaC-b relative to α ENaC full-length in 
kidney, lung, and taste tissues of Dahl rats. 2) To compare the expression (mRNA and protein) of α ENaC-b in kidneys of 
Dahl S and R rats on regular and high salt diet. 3) To examine the putative binding of α ENaC-b proteins to full-length α 
ENaC in vitro and to determine the impact of such binding on full-length α ENaC expression in vitro.
Implications of the hypothesis: Our studies will be the first to demonstrate the over-expression of salt-sensitive α 
ENaC-b spliced form in kidney tissues of Dahl R rats at the expense of full-length α ENaC. The current proposal will 
provide highly novel insights into the putative mechanisms leading to ENaC hypoactivity in high-salt-fed Dahl R rats. 
Finally, findings from the present proposal will uncover a new mechanism by which alternative splicing may control 
the regulation of ENaC expression/function.
Background
The amiloride-sensitive Epithelial Sodium Channel
(ENaC) constitutes the major route for transporting the
sodium ion (Na+) into the cell and hence, is critical in the
maintenance of Na+ balance, extracellular fluid volume
and long term blood pressure control. ENaC is primarily
composed of three subunits denoted by α, β, & γ. α ENaC
subunit is critical for channel functionality, while β & γ
subunits serve to maximize channel functionality. As
such, being the most critical subunit in channel function-
ality, α ENaC is the focus of the present hypothesis. To
date, there are four alternatively spliced forms of the α
subunit of ENaC (α ENaC-a, -b, -c & -d) that have been
published in rats, in addition to the major α ENaC tran-
script [1,2]. α ENaC-a, -c & -d transcripts are low abun-
dance transcripts compared to full-length α ENaC and
have been defined in terms of expression. Additionally, α
ENaC-a has demonstrated non-functionality in oocytes
a s  w e l l  a s  b i n d i n g  t o  E N a C  b l o c k e r  [ 1 ] .  O n  t h e  o t h e r
hand, α ENaC-b is yet to be fully characterized, but
appears to play a role in modulating ENaC, for the follow-
ing reasons: a) α ENaC-b mRNA expression is signifi-
cantly higher in Dahl salt-resistant (R) rats (with
suppressed Na+ transport related to ENaC [3,4]) versus
Dahl salt-sensitive (S) rats [2] (with enhanced Na+ trans-
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port related to ENaC [3,4]); b) α ENaC-b is a salt-sensitive
transcript, because high versus normal salt diet caused a
large increase in α ENaC b mRNA (P ‹ 0.05) levels in Dahl
R rats [2]; c) unlike α ENaC-a, -c &-d, α ENaC-b mRNA
levels are ~32 ± 3-fold higher than full-length α ENaC;
and finally d) the splice site generating α ENaC-b is highly
conserved across species. As such, our results demon-
strate a clear shift from constitutive to alternative splicing
of α ENaC pre-mRNA in favor of α ENaC-b formation,
indicating an increased stability and/or preferential syn-
thesis of the latter.
These facts, combined with the realization that large
structural defects in an encoded protein (such as α ENaC-
b) are usually associated with considerable effects on pro-
tein function that may extend to a drastic switch-off
effect [5], in turn, emphasize the need for investment in
basic research with a view to identifying novel targets for
diagnosis, prevention and treatment of disorders related
to ENaC dysfunction. The overall objective of these stud-
ies is to continue to examine the differential expression of
α ENaC-b relative to full-length α ENaC in an array of tis-
sues where ENaC plays a significant role. Subsequently,
we will investigate whether α ENaC-b suppresses α ENaC
expression/activity by binding to and/or accelerating pro-
teolytic degradation of the latter in Dahl R rats (a model
of suppressed ENaC). As such, we will pursue the follow-
ing three specific aims:
A. What is the comparative expression profile of α ENaC-b 
in kidney, lung and taste tissues of Dahl S and R rats fed 
regular salt diet?
We will continue to define the existence and later exam-
ine the mRNA and protein expression profiles of α ENaC-
b compared to full-length α ENaC in Dahl rat kidney
(already reported in our previous contribution [2]), lung
and taste tissues where ENaC plays a significant role.
Cell-specific expression of α ENaC-b might allow partic-
ular cell types to individually regulate ENaC expression/
function.
B. Is α ENaC-b over-expressed in response to salt loading in 
kidneys of Dahl R rats with suppressed ENaC activity 
compared to Dahl S rats with overly active ENaC?
We will narrow our studies to studying the impact of high
dietary sodium on α ENaC-b expression in Dahl rat kid-
ney tissues. We will continue our QRT-PCR experiments
that demonstrated an enhanced mRNA [2] and will fol-
low by Western analysis to examine protein expression of
α ENaC-b in kidneys of Dahl R compared to S rats on
high  versus  regular salt diet. We will then proceed to
quantify α ENaC-b expression relative to full-length α
ENaC in Dahl R versus S rats. These studies will show
whether suppressed full-length α ENaC expression in
Da h l  R  r a ts  is  c o n s i s t e n t  wi t h  a n  e n h a n c ed  α  EN a C - b
mRNA and protein levels.
C. Does α ENaC-b protein interact with and/or directly bind 
to full-length α ENaC and subsequently alter full-length α 
ENaC expression?
We will proceed to examine if α ENaC-b protein seques-
ters full-length α ENaC (by co-immunoprecipitation
assays). The impact of α ENaC-b on full-length α ENaC
expression has been elucidated (dose-dependent co-
expression experiments) in cellular models (as recently
reported in our studies [6]). These co-immunoprecipita-
tion studies along with our previously reported western
analyses will demonstrate the mechanism by which α
ENaC-b contributes to a suppressed overall Na+ transport
r e l a t e d  t o  E N a C  i n  D a h l  R  r a t s  o n  h i g h  N a + (e.g., by
enhanced binding of α ENaC-b to full-length α ENaC, fol-
lowed by proteolytic degradation of the latter).
Presentation of the hypothesis
General Hypothesis
α ENaC-b protein, which is preferentially produced in
Dahl R rats, to a greater extent on high salt diet, exerts a
dominant negative effect on full-length α ENaC subunit
by physically binding to and trapping full-length α ENaC
subunit in the endoplasmic reticulum, and finally acceler-
ating full-length α ENaC proteolytic degradation in a
dose-dependent manner.
Specific Hypotheses
▪ α ENaC-b is differentially expressed in the kidneys,
lungs and taste tissues of Dahl rats to individually regu-
late ENaC expression/function in these tissues.
▪ At the expense of full-length α ENaC expression lev-
els, α ENaC-b expression (mRNA and protein) is
enhanced in response to salt, in kidneys of Dahl R, but
not S rats to suppress α ENaC expression/activity.
▪ α  E N a C - b  p r o t e i n s  t r a p  f u l l - l e n g t h  α  E N a C  i n  t h e
endoplasmic reticulum and enhance full-length α ENaC
proteolytic degradation in a dose-dependent manner and
hence serve as dominant negatives on α ENaC expres-
sion/activity.
Objectives
1. To examine the abundance of α ENaC-b relative to α
ENaC full-length in kidney, lung, and taste tissues of Dahl
rats.
2. To compare the expression (mRNA and protein) of α
ENaC-b in kidneys of Dahl S and R rats on regular and
high salt diet.
3. To examine the putative binding of α ENaC-b pro-
teins to full-length α ENaC in vitro and to determine the
impact of such binding on full-length α ENaC expression
in vitro.Shehata International Archives of Medicine 2010, 3:14
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Rationale
Owing to the established body of evidence pointing out
the crucial role of alternatively spliced forms (particularly
those lacking important functional domains) as dominant
negative variants on full-length proteins [7-9], we chose
to examine the putative role of alternatively spliced form
α ENaC-b in ENaC regulation for the following six rea-
sons: a) α ENaC-b mRNA levels are ~32 ± 3-fold higher
than full-length α ENaC in kidneys of Dahl rats [2], indi-
cating increased stability and/or synthesis of the former,
b) α ENaC-b mRNA concentrations are significantly
higher in Dahl R versus S rat kidneys on regular salt diet
[2], c) At the expense of full-length α ENaC protein, Dahl
R rats kidney tissues may demonstrate enhanced expres-
sion of α ENaC-b compared to the full-length α ENaC; d)
α ENaC-b is a salt-sensitive transcript, because high ver-
sus normal salt diet caused a large increase in α ENaC-b
mRNA levels (P < 0.05) in Dahl R rats [2,10], e) the splice
site used to generate α ENaC-b is conserved in humans,
f) α ENaC-b is translatable [2,6] (Translate tool® http://
ca.expasy.org/tools/dna.html). Consistent with the puta-
tive role of α ENaC-b in ENaC dysregulation, our previ-
ously reported results are consistent with a dominant
negative effect imposed by α ENaC-b on full-length α
ENaC [6]. Dahl R and S rats serve as attractive models to
study the contribution of α ENaC-b on differential ENaC
expression and activity. This is because on high salt diet,
Dahl R, but not S rat kidneys have a suppressed Na+
transport related to ENaC [3,4]. Our findings could pro-
vide novel targets for regulating α ENaC congener levels
by manipulating the expression of the alternatively
spliced form-b or by expressing an exogenous α ENaC-b.
Our current proposal examines three potential mecha-
nisms by which α ENaC-b may regulate the renal full-
length α ENaC by a dominant negative effect. The first
mechanism is through suppressing α ENaC transcrip-
tion via a shift from constitutive to alternative splicing of
α ENaC pre-mRNA in favor of α ENaC-b formation. The
second mechanism is through suppressing translation
of full-length α ENaC more prominently in Dahl R versus
S rats. The third mechanism is via an enhanced binding
of α ENaC-b protein to the full-length α ENaC and accel-
erated degradation of the latter as a result of direct bind-
ing to α ENaC-b, a phenomenon that has been reported
previously in several other channels and membrane pro-
teins [7-9,11-13]. Enhanced binding of α ENaC-b to the
full-length α ENaC might trap α ENaC in the endoplas-
mic reticulum and/or inhibit proper ENaC assembly and
trafficking to the plasma membrane, resulting in the for-
mation of non functional channels. On the other hand,
suppressing α ENaC full-length protein expression will, in
turn, disturb the proportions of the ENaC αβγ proteins to
be translocated to the plasma membrane and ultimately
hinder overall channel cell surface expression and activ-
ity.
Knowledge of the mechanism by which α ENaC-b regu-
lates full-length α ENaC and possibly reduces expression/
activity of ENaC in Dahl R rats and the subsequent gene-
sis of salt-dependent hypertension [a disease that com-
prises a large subgroup (over 50%) of Canadian adults]
would enhance the understanding of the basic regulation
of ENaC and the pathophysiology of ENaC-associated
disorders such as salt-sensitive hypertension. It may also
create one or more specific targets for the development of
novel anti-hypertensive drug or gene therapy.
Testing the hypothesis
Animal models
Dahl S rats are used as a genetic model for enhanced
ENaC activity. ENaC activity is twice in Dahl S kidney
versus Dahl R kidney [3,4]. In contrast, Dahl R rats are the
primary control strain with suppressed ENaC function.
Usually, 8-10 rats per group are sufficient for statistical
significance. Our research plan can be summarized as fol-
lows:
▪ We plan to examine the expression (mRNA and pro-
tein) of α ENaC-b relative to α ENaC wt in lung, kid-
ney and taste tissues of Dahl S and R rats.
▪ We will subsequently proceed to investigate the 
effect of salt loading on the expression (mRNA and 
protein) of α ENaC-b in kidneys of Dahl rats. We 
already published the mRNA levels of α ENaC-b in 
kidney cortex of Dahl S versus R rats on normal and 
high salt diet [2]. We will continue by studying the 
mRNA levels and protein levels in kidney medulla.
▪ Finally, we will continue examining α ENaC-b het-
erodimerization with full-length α ENaC, and the 
impact of such heterodimerization on full-length α 
ENaC expression (using COS7 cells, antibodies, co-
immunoprecipitation assays and dose-dependent 
expression studies [6]).
Experiments will be performed on male Dahl S and R
rats (n = 24), 3-4 weeks of age, obtained from Harlan
Sprague Dawley (Indianapolis, IN) and handled as previ-
ously described [2,6,14,15]. The rats will be divided into 4
groups (6 rats/group) by placing them on either regular
(normal) (120 μmol Na+/g) or high-salt (8% NaCl or 1,370
μmol Na+/g, Teklad; Madison, WI) diet for four weeks.
After 4 wks, blood pressure (BP) will be measured inva-
sively by intra-arterial catheter and the average mean
arterial pressure will be estimated. The animals will then
be killed by decapitation and kidney, lung and tongue tis-
sues will be removed and placed in cold methylbutane
and then on dry ice. Tissues will be preserved at -80°C for
later protein and RNA isolation. All experiments will be
carried out in accordance with the guidelines of the Uni-Shehata International Archives of Medicine 2010, 3:14
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versity of Ottawa Animal Care Committee for the care
and use of laboratory animals.
Specific Methodology
Aim 1: What is the expression profile of α ENaC-b in kidney, 
lung and taste tissues of Dahl S and R rats?
To determine the mRNA and protein expression levels of
α ENaC-b versus full-length α ENaC, we will isolate pro-
tein and total RNA from kidney, lung and taste tissues.
T h e n  w e  w i l l  p r o c e e d  b y  p e r f o r m i n g  w e s t e r n  a n a l y s e s
and QRT-PCR to examine and later quantify α ENaC pro-
teins and mRNAs. Detailed protocols are as follows:
Protein and RNA isolation Whole kidney, lung and
tongue tissues are homogenized with polytron. Total pro-
tein and total RNA are isolated using Trizol reagent
(Invitrogen, CA, USA) according to the manufacturer's
protocol. Isolated RNA is subjected to DNAse treatment
for removing potential genomic DNA contamination
using DNase treatment kit (Ambion). The availability of
an antiserum specific for α ENaC proteins (directed
against the N-terminus amino acid residues 46-68 of the
rat α ENaC) will allow us to probe for these proteins in
kidney, lung and tongue cell homogenates.
Reverse transcription 2 μg mRNA is reverse transcribed
to first strand cDNA by superscript II RNase H- Reverse
transcriptase (Invitrogen, CA, USA). To examine the co-
existence of α ENaC wt and -b form, we will utilize wt
primers that are common between α ENaC wt and -b
form (no C-terminus sequence is shared among the two
forms together). For QRT-PCR, we will use primers that
are designed specifically to amplify the α ENaC -b form
by including the nucleotide deletions (79 bp in α ENaC-b
reverse primer). For α ENaC wt sequence, we will use the
GeneBank accession number NM_031548 (α ENaC wt
sequence was confirmed by our previously published
study [15]), and for α ENaC -b, we will use the sequence
previously reported by us [2].
Cloning Full-length α ENaC and alternatively spliced
form -b are cloned using DH5 α competent cells, and
TOPO TA cloning kit® (Invitrogen, ON, Canada). The
resulting clones are sequenced using ABI prism 3100 (PE
Applied Biosystems, Foster City, CA). Sequencing is per-
formed using the DYEnamic ET Terminator kit according
to the instructions provided by the manufacturer (PE
Applied Biosystems, Foster City, CA). Sequencing prod-
ucts are purified (DyeEx 2.0 spin kit columns; Qiagen
Canada, Mississauga, ON, Canada).
Quantitative real-time PCR cDNAs are amplified using
the previously described primers for wt α ENaC and α
ENaC-b form. The relative amount of full-length α ENaC
and alternatively spliced form mRNA are measured by
quantitative real time RT-PCR using Roche light cycler
and Fast Start DNA master SYBR Green I dye. Known
plasmid concentration is used as a calibrator and water is
used as negative control for each reaction. Experiments
are done in triplicates for each form (full-length and -b
form). Melting curve analysis is performed for each reac-
tion to assess product specificity. Products are visualized
on gel using gel electrophoresis assay to confirm the cor-
rect product sizes. Normalization is done using 3-phos-
phoglycerate-kinase (PGK) as a housekeeping gene.
Electrphoresis Analysis (Western Blot Analyses) Con-
centrations for whole kidney, lung and tongue proteins
(and proteins harvested from cultured cells under aim 3)
are measured by Bradford. Proteins are then separated by
SDS-PAGE resolving gels containing 10% acrylamide, and
4% of the same solution for stacking gels (NuPAGE Bis-
Tris gels, Invitrogen). Briefly, 20 μg of proteins are mixed
with 100 μl 2 × SDS-PAGE sample buffer containing 0.1%
SDS (sodium dodecyl-sulphate (w:v)) and supplemented
with β-mercaptoethanol. Before loading, SDS samples are
heated at 100°C for 5 minutes. Samples are then trans-
ferred onto a nitrocellulose membrane (Invitrogen) and
incubated with primary (directed against α ENaC N-ter-
minus) at a 1:1000 dilution. Blots are washed thrice for 5
minutes each with PBST. For standard Western blotting
detection, blots are incubated with either an anti-rabbit
HRP-conjugated antibody (1:10,000, Amersham), for 1 h
at 25°C. For improved Western blotting detection to
avoid HC and LC signals, blots are incubated (1 h at 25°C)
with a 1:5,000 dilution of Protein A-HRP (Amersham) or
a 1:10,000 dilution of Protein G-HRP (Upstate Biotech.),
prepared in blocking buffer. After washing three times at
25°C with PBST (5 min each), blots are developed with
ECL Plus (Amersham). The marker used is high range
Biorad ladder catalogue 161-0309.
Corresponding protein bands for α ENaC-b will be later
sequenced for confirming the protein sequence of α
ENaC-b. We will be using Cambridge Peptides®  for
sequencing α ENaC proteins http://www.cambridgepep-
tides.com/index.html.
Aim 2: Is α ENaC -b over-expressed in Dahl R rats with 
suppressed ENaC activity compared to Dahl S rats with overly 
active ENaC in response to salt loading?
Protein, total RNA extraction, QRT-PCR and western
blot analyses will be performed as described under Aim 1.
Dahl rats fed either regular or high salt diet will be exam-
ined for α ENaC-b expression versus full-length α ENaC
in kidney tissues.
Statistical Analysis
Differences between the expression levels of full-length α
ENaC and alternatively spliced form -b will be analyzed
in Dahl S versus R rats on normal and high salt diet using
two way ANOVA (SigmaSTAT®). The statistical test is
two sided to identify strain and dietary differences, the
data will be expressed as means and ranges, and differ-Shehata International Archives of Medicine 2010, 3:14
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ences of P values of less than 0.05 will be considered as
significant.
Aim 3: Does α ENaC-b protein directly bind to full-length α 
ENaC and subsequently alter full-length α ENaC expression?
RNA extraction, RT-PCR and PCR To amplify full-
length α ENaC and α ENaC-b for expression studies, spe-
cific primers will be designed to flank the open reading
frames of full-length α ENaC and -b forms. High fidelity
Expand Long Range, dNTPack (Roche Applied Science®,
Quebec, Canada) will be employed to amplify full-length
α ENaC wt and -b spliced form. Touchdown PCR method
will be employed to improve the efficiency of gene ampli-
fication as follows (start Tm at 68°C and the annealing
temp reduced 2°C per cycle for the next cycles up to Tm =
58, then the remaining cycles at a 58°C annealing temper-
ature). After amplification, the specific fragments of full-
length α ENaC and α ENaC-b will be visualized in 1%
agarose gels.
Plasmids and Generation of Constructs PCR products
for α ENaC wt and -b form will be ligated with with
pCR®2.1-TOPO® vector using the TOPO TA® cloning kit
(Invitrogen, CA, USA), with blue/white screening of
DH5α competent cells on ampicillin selective plates. Pos-
itive clones will be cultured in LB broth. DNA extracted
from these cultures using Qiagen DNA miniprep kit, will
be sequenced using the M13 universal forward and
reverse primers, in addition to embedded primers within
α ENaC wt and -b forms to verify their full-lengths.
Sequencing will be performed using the DYEnamic ET
Terminator kit according to the instructions provided by
the manufacturer (PE Applied Biosystems, Foster City,
CA). The sequence of the cloned α ENaC-b form is com-
pared to the one previously reported [1,2], and the
sequence of the full-length α ENaC is compared to the
one previously reported for Dahl rats [15].
Ligated pCR®2.1-TOPO®  - α ENaC wt clone will be
digested using EcoR1, while that of α ENaC-b with EcoRV
and HindIII and then subcloned overnight at 16°C into
PCMV-sport6 vector (Invitrogen, CA, USA) downstream
the T7 promotor using the EcoRI site for α ENaC wt and
the EcoRV and HindIII sites for α ENaC-b.
Cell culture and transfection COS-African green mon-
key kidney cells will be maintained in culture at 37°C/5%
CO2 using Dulbecco's Modified Eagle's Medium
(DMEM, Hyclone® Thermo Fisher Scientific Laboratories,
Logan, UT) supplemented with glutamine and 10% heat-
inactivated foetal bovine serum (FBS, PAA Laboratories).
Transfections will be performed using lipofectamine
2000 reagent (Invitrogen, Carlsbad, CA) and up to 50 μg
DNA per 10 cm plate. Immediately before transfection
the culture medium will be replaced with 5 ml of DMEM
supplemented with 10% (v/v) fetal bovine serum. PCMV-
sport6/α ENaC wt and b forms will be transfected into
COS-7 cells separately at a concentration of 24 μg DNA/
plate, as well as co-transfected together in a 1:1 ratio of α
ENaC wt: α ENaC-b. For dose-dependent expression
experiments, α ENaC and α ENaC-b form will be trans-
fected into COS-7 cells separately at a concentration of
24 μg DNA/plate, as well as co-transfected together in a
dose-dependant manner as follows (full-length α ENaC: α
ENaC-b is (8: 1 μg, 8:3 μg, 8:6 μg, 8: 12 μg, 8: 18 μg, 8: 24
μg, 8: 30 μg, 8: 42 μg). The empty PCMV-sport6 vector at
a concentration of 24 μg DNA/plate will be transfected as
a control. Then the cells will be harvested for > 2 h at 4°C
in RIPA lysis buffer (10 mM NaPO4, 150 mM NaCl, 1%
deoxycholate, 1% Triton X-100, and 0.1% SDS, pH 7.2)
supplemented with the protease inhibitor cocktail
(Sigma, St Louis, MO). Proteins will be handled and sepa-
rated by electrophoresis as described under Aim 1.
Co-immunoprecipitation Assay Co-immunoprecipita-
tion (Co-IP) will be employed to identify interaction
between α ENaC-b and full-length α ENaC. Co-IP is con-
ducted in essentially the same manner as a western blot
(see aims 1 and 2 above). However, in a co-IP, α ENaC tar-
get antigen precipitated by the antibody against α ENaC
"co-precipitates" a binding α ENaC-b complex from a
lysate, i.e., the interacting protein is bound to the target
antigen, which becomes bound by the antibody that
becomes captured on a Protein A or G gel support (Pierce
kit®).
Implications of the hypothesis Depending on the
results obtained from the proposed studies, we will pro-
ceed to examine the sub-cellular localization of α ENaC-b
(if localized in the cytosolic and/or particulate fractions)
using immunohistochemistry and the same antibodies
used in the present proposal. Then, we will again employ
immunohistochemistry to investigate if the co-localiza-
tion of α ENaC-b with α ENaC wt is perinuclear (such as
in endoplasmic reticulum) or closer to the plasma mem-
brane. Results from these studies will demonstrate if het-
eromerization of α ENaC-b with α ENaC wt traps the
latter in the endoplasmic reticulum, or it still allows α
ENaC wt migration to the plasma membrane. Then, it
would be interesting to examine the impact of α ENaC-b
on ENaC cell surface expression. We will use the same
procedure employed by Firsov and colleagues in [16],
where α ENaC-b together with, β, and γ rat ENaC sub-
units will be tagged with the FLAG reporter octapeptide
(DYKDDDDK) that is recognized by the anti-FLAG M2
(M2Ab) mouse monoclonal antibody (Kodak). Then,
expression in Xenopus oocytes and binding assays
(immunoprecipitation) will follow. Results from this set
of experiments will reveal if α ENaC-b suppresses ENaC
cell surface expression.
To this end, we will proceed and assess the overexpres-
sion of α ENaC-b in Dahl S rats where α ENaC-b expres-
sion is suppressed compared to Dahl R rats. AShehata International Archives of Medicine 2010, 3:14
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replication-defective adenovirus (AV) will be used as the
vector for delivery of over-expression sequences, as pre-
viously described [17]. Injecting AV in the CNS maintains
the high levels of AV for at least 28 days post i.c.v. because
of a diminished immune response in the CNS versus the
periphery. There are at least two areas of potential clinical
importance for these studies. First, identification of
spliced forms that impair the hyperactivity of ENaC to
sodium in the kidney of Dahl S rats would identify spe-
cific targets for the development of novel antihyperten-
sive drug therapy for salt-dependent hypertension.
Second, as gene therapy delivery systems continue to
evolve, we will be examining in vivo delivery of adenovi-
ruses carrying α ENaC-b and then assessing the resultant
blood pressure effects. This may eventually gain rele-
vance as a possible "proof-of-concept" gene therapy.
Conclusion
Our studies will be the first to demonstrate the over-
expression of salt-sensitive α ENaC-b spliced form in kid-
ney tissues of Dahl R rats at the expense of full-length α
ENaC. The current proposal will provide highly novel
insights into the putative mechanisms leading to ENaC
hypoactivity in high-salt-fed Dahl R rats. Finally, findings
from the present proposal will uncover a new mechanism
by which alternative splicing may control the regulation
of ENaC expression/function.
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